THE POLICY LANDSCAPE

Rights, restrictions & the places between.

KY HB501 (2025)

AN ACT relating to pharmaceutical drugs.

Anti-LGBTQ+

Jurisdiction
Kentucky
Session
2025 Regular Session
Stage reported
Passed / adopted
First recorded action
Latest action
: became law without Governor's Signature (Acts Ch. 161)
Record retrieved

Bill types

As labelled in the project's tracker.

Gender Affirming Care Ban: Medicaid

Links

Recorded actions

KY HB501: recorded actions
DateChamberAction
Houseintroduced in House
Houseto Committee on Committees (H)
Houseto Health Services (H)
Housereported favorably, 1st reading, to Calendar
House2nd reading, to Rules
Houseposted for passage in the Regular Orders of the Day for Tuesday, March 04, 2025
Housefloor amendment (1) filed
House3rd reading, passed 97-0 with Floor Amendment (1)
Senatereceived in Senate
Senateto Committee on Committees (S)
Senateto Health Services (S)
Senatereported favorably, 1st reading, to Calendar
Senate2nd reading, to Rules
Senatefloor amendments (1-title) and (2) filed
Senateposted for passage in the Regular Orders of the Day for Friday, March 28, 2025
Senate3rd reading, passed 38-0 with Floor Amendment (2) and Floor Amendment (1-title)
Housereceived in House
Houseto Rules (H)
Houseposted for passage for concurrence in Senate Floor Amendment (2) and Floor Amendment (1-title)
HouseHouse concurred in Senate Floor Amendment (2) and Floor Amendment (1-title)
Housepassed 83-16
Houseenrolled, signed by Speaker of the House
Houseenrolled, signed by President of the Senate
Housedelivered to Governor
Housefiled without Governor's signature with the Secretary of State
Housebecame law without Governor's Signature (Acts Ch. 161)

Legislative status and legal enforcement are different. See the policy areas and the court sources they cite for enforcement.

Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. Used here in modified form.